Aim: Urine podocin mRNA expression and urine podocin : nephrin mRNA expression ratio (PNR) increase with increasing proteinuria during pregnancy complicated with pre-eclampsia (PE). This suggests that urine podocytes with reduced nephrin mRNA expression are abundant in pathological podocyturia. The aim of this study was therefore to determine post-partum changes in podocyturia and PNR in relation to proteinuria after pre-eclampsia (PE). Methods: A total of 137 peripartum urine specimens, consisting of 72 and 65 from 24 and 30 women with PE and normotensive control pregnancies (NCP), respectively, were studied. Determination of urine protein and creatinine concentration and quantitative analysis of podocyte-specific podocin and nephrin mRNA expression were carried out using reverse transcription-polymerase chain reaction in pelleted urine samples. Podocyturia was monitored via urine podocin mRNA expression. Podocyturia and proteinuria were normalized by urine creatinine concentration. Results: Podocyturia and urine PNR decreased with decreasing proteinuria as well as with increasing time after delivery in the urine from PE women. In physiological proteinuria (i.e. protein : creatinine ratio [P/Cr] 0.005-0.1 mg/mg), however, both podocyturia and PNR were significantly greater in the urine from PE women compared with NPC women, although P/Cr was similar between the groups (median, 0.037 mg/mg for PE vs 0.029 mg/mg for NCP). Conclusions: Podocyturia decreases with decreasing proteinuria in PE women after childbirth. In PE women, however, pathological podocyturia consisting of podocytes with decreased nephrin mRNA expression persisted even after proteinuria decreased to a level similar to that in NCP women.
Introduction
Podocytes that line the outer layer of the glomerular basement membrane (GBM) form the final barrier to protein loss from the kidney. 1 Podocytes detach from the GBM and are present in the urine (as podocyturia) in various proteinuric diseases, including pre-eclampsia (PE). [2] [3] [4] [5] [6] [7] Given that podocytes are terminally differentiated cells 1 and their turnover rate is very low, 8, 9 the detachment of glomerular podocytes from the GBM contributes to a decrease in the number of glomerular podocytes in the kidneys. 1, 10 Podocyturia can be monitored via mRNA expression of podocyte-specific proteins, such as podocin and nephrin, 7, 11, 12 and increases with increasing proteinuria in pregnancy complicated with PE. 7, 11, 12 Certain stimuli, however, cause alteration of the phenotype of glomerular podocytes, that is, reduced nephrin mRNA expression in the glomerular podocytes (i.e. in animal models), and such glomerular podocytes with reduced nephrin mRNA expression are likely to detach from the GBM, resulting in increases in urine podocin : nephrin mRNA ratio (PNR). 13 Indeed, urine PNR increases with increasing podocyturia in PE women. 7 Thus, podocytes with reduced nephrin mRNA expression are abundant in pathological podocyturia in PE women. Therefore, urine podocin mRNA level, but not nephrin mRNA expression level, reflects the degree of podocyturia. Proteinuria decreases after birth, and podocyturia has also been suggested to decrease after birth in PE women.
14 Post-partum changes in podocyturia and urine PNR in relation to proteinuria, however, remain to be studied. The present study was performed to determine post-partum changes in podocyturia as reflected by podocin mRNA expression and urine PNR in PE women.
Methods Participants
This study was conducted in accordance with the principles of the Declaration of Helsinki and with the approval of the Institutional Review Board of Hokkaido University Hospital. All women gave written informed consent prior to participation in this study. A total of 54 women consisting of 30 with normotensive control pregnancies (NCP) and 24 with PE participated in this study and gave birth at Hokkaido University Hospital during the study period from June 2014 to July 2016 (Table 1) . No women with known hypertension or renal disease were included in this study. PE was diagnosed in women with both hypertension and significant proteinuria in pregnancy (SPIP) for the first time on or after gestational week (GW) 20. Dipstick test was exclusively negative for proteinuria performed at antenatal care before GW 20 in all 24 PE women.
Protein : creatinine ratio (P/Cr) was determined before GW 20 in 10 of the 24 with later PE; median P/Cr was 0.042 mg/mg (range, 0.002-0.064 mg/mg) for the 10 women at GW 17.9 (range, 13.7-19.7). SPIP and hypertension was noted for the first time at GW 32.2 (range, 24.4-39.1) and at 32.6 (range, 24.4-40.4), respectively in the 24 PE women (Table 1) . Thus, no women with hypertension or SPIP before GW 20 were included in this study. SPIP was defined as P/Cr > 0.27 mg/mg (corresponding to 30 mg/mmol) in spot urine specimens. Hypertension was diagnosed in women with systolic blood pressure ≥140 mmHg and/or diastolic blood pressure ≥90 mmHg on at least two occasions >12 h apart. A total of 47 antepartum and 90 post-partum urine specimens were provided by the 54 women participating in the study (Table 1) . Post-partum urine samples on post-partum days (PPD) 5-9, 20-45, and 50-120 (designated as PP1, PP2, and PP3, respectively).
All 137 urine specimens were coded and processed within 2 h of collection. Urine samples were centrifuged at 700 × g for 5 min. Urinary supernatant was stored at À20°C until measurement of protein and creatinine. Pelleted urine samples were suspended in RNAlater (Life Technologies, Carlsbad, CA, USA) and stored at À20°C until isolation of RNA. Protein and Cr concentration were measured using Protein Assay Rapid Kit Wako and Laboassay Creatinine (Wako Pure Chemical Industries, Osaka, Japan), respectively. Urine protein concentration was corrected by urine Cr and expressed as P/Cr (mg/mg). *P < 0.05 vs pre-eclampsia group; †collected within 2 weeks before delivery. GW, gestational weeks; NA, not applicable; NCP, normotensive control pregnancy; PE, pre-eclampsia; PPD, post-partum day; SPIP, significant proteinuria in pregnancy (protein : creatinine ratio (mg/mg) > 0.27).
Quantitative real-time polymerase chain reaction
RNA isolation from the pelleted urine and reverse transcription reaction were performed as described previously. 7 Absolute podocin, nephrin, and aquaporin 2 mRNA were quantified using an ABI Prism 7300 Sequence Detection System (Applied Biosystems, Foster City, CA, USA) with Power SYBR Green PCR master mix (Thermo Fisher Scientific, Yokohama, Japan) and sample cDNA in a final volume of 15 μL per reaction. The following primers were used: podocin: forward, 5'-AAGAGTAATTATATTCCGACT GGGACAT-3'; reverse, 5'-TGGTCACGATCTCATG AAAAGG-3'; nephrin: forward, 5'-CAACTGGGAGA GACTGGGAGAA-3'; reverse, 5'-AATCTGACAAC AAGACGGAGCA-3'; aquaporin-2: forward, 5'-TGGG CCATATGTGCTATGGAGA-3'; reverse, 5'-AAGGAC ACTCAGGTGCCAGGA-3'. The thermal cycling conditions were 95°C for 10 min, followed by 40 cycles of 15 s at 95°C and 1 min at 60°C. All data were constructed from 0.5-μL samples analyzed in triplicate. The polymerase chain reaction (PCR) product of each gene was used as a standard, and the standard curve was established with 10-fold serial dilutions of the product. The transcript numbers were determined from linear regression of these standard curves. Given that the quantity of RNA extracted from the pelleted urine varied, aquaporin-2 mRNA was used as a kidney-specific reference gene unrelated to glomerular injury. The limit of detection for podocin, nephrin, and aquaporin-2 mRNA expression was 100 copies/reaction. In this study, only urine specimens with >500 copies aquaporin-2 mRNA per real-time PCR were used for analysis. Samples with undetectable levels of podocin or nephrin mRNA, but a detectable level of aquaporin-2 mRNA expression, were assumed to contain 100 copies/reaction of the target.
Statistical analysis
Data are presented as median (range). Statistical analysis was performed using JMP10 (SAS, Cary, NC, USA). Kruskal-Wallis test with Bonferroni correction was used for comparisons between three or more groups. Differences in frequencies were examined using Fisher's exact test. Spearman rank order correlation was used to test associations between two variables. In all analyses, P < 0.05 was taken to indicate statistical significance, but significant correlation between two variables was defined as P < 0.05 and correlation coefficient (R) > 0.2.
Results
Aquaporin 2 mRNA expression was detectable at >500 copies per real-time PCR in all 137 urine specimens. In 24 antepartum and 48 post-partum urine specimens from PE women, podocin mRNA expression was undetectable in none (0.0%) and in one (2.1%), respectively, and nephrin mRNA was undetectable in none (0.0%) and in one (2.1%), respectively. In 23 antepartum and 42 post-partum urine specimens from NCP women, podocin mRNA expression was undetectable in two (8.7%) and in five (11.9%), respectively, and nephrin mRNA was undetectable in one (4.3%) and in six (14.3%), respectively.
Changes in parameters with time after childbirth
Podocin and nephrin mRNA expression decreased with increasing number of days after childbirth in PE women (Fig. 1) , indicating a decrease in the number of podocytes with increasing number of days after childbirth. PNR was markedly high before birth and at PP1 (Fig. 1) , indicating markedly reduced nephrin mRNA expression compared with podocin mRNA expression in urine with abundant podocytes. PNR, however, decreased with decreasing number of urine podocytes. This indicates that gradual increase in nephrin mRNA expression occurred in each urine podocyte with increasing number of days after childbirth in PE women.
In NCP women, all parameters except nephrin mRNA expression decreased significantly from the 23 antepartum urine samples to the 42 post-partum urine samples: P/Cr 0.05 mg/mg (range, 0.004-0.109 mg/mg) decreased to 0.02 mg/mg (range, 0.001-0.105 mg/mg; P = 0.0022), podocin mRNA expression 4.45 copies/mg Cr (range, 0.14-51.2 copies/mg Cr) decreased to 0.63 copies/mg Cr (range, 0.056-71.5 copies/mg Cr; P = 0.0005), and PNR 1.65 (range, 0.17-11.3) decreased to 0.69 (range, 0.05-2.70; P < 0.0001). Nephrin mRNA expression was 2.87 copies/mg Cr (range, 0.12-31.7 copies/mg Cr) and 1.46 (range, 0.06-26.8 copies/mg Cr; P = 0.4104) before and after delivery, respectively. Post-partum decrease in podocin mRNA expression in NCP women suggested increased podocyturia even in NCP pregnancies, confirming the results of a previous study. 15 Correlations with P/Cr in post-partum urine samples Podocin mRNA expression, nephrin mRNA expression, and PNR all decreased with decreasing P/Cr in post-partum urine samples from PE women (Fig. 2) , indicating that post-partum podocyturia also decreased with decreasing proteinuria. The slope of the linear regression line, however, was more gentle for PNR than for podocin mRNA. This suggests that nephrin mRNA expression was still reduced in each urine podoctye even after proteinuria decreased to a level similar to that in NCP women.
Physiological proteinuria
To determine whether degree of podocyturia and podocyte phenotype in the urine from PE women differed from those in the urine from NCP women, urine samples with P/Cr 0.005-0.1 mg/mg were chosen from both groups to match P/Cr level (Fig. 2) . In 31 versus 19 urine samples with P/Cr 0.005-0.1 mg/mg from NCP versus PE women, respectively, P/Cr was similar, but podocin mRNA expression, nephrin mRNA expression, and PNR were all significantly greater in the PE than NCP urine samples (Fig. 3) . As suggested based on Figure 2 , high podocin mRNA expression, nephrin mRNA expression, and PNR were characteristic features in SPIP urine samples (Fig. 3) . Thus, even in the urine of PE women containing physiological proteinuria, podocyturia was still high and nephrin mRNA expression in each urine podocyte was still low compared with NCP women.
Discussion
This study was performed to examine post-partum urine samples, and the findings can be summarized as follows: (i) podocyturia monitored via podocin mRNA Red line, linear regression for PE samples. Urine samples with P/Cr 0.005-0.1 XX and those with significant proteinuria in pregnancy (P/Cr > 0.27) were used for further analysis (Fig. 3) . expression as well as nephrin mRNA decreased with decreasing proteinuria as well as increasing number of days after childbirth in women following PE pregnancy; (ii) PNR decreased with decreasing proteinuria as well as with increasing number of days after childbirth in women following PE pregnancy; and (iii) both podocyturia and PNR were greater in the urine from women following PE pregnancy than in those from women following NCP, even though P/Cr was similar. Generally, changes occurring in pregnant women, for example maternal weight, circulating blood volume, and blood pressure in PE women, gradually return to non-pregnancy levels after childbirth. Given that podocyturia increases with increasing proteinuria until childbirth in PE women, 7 it was expected that podocyturia would decrease with decreasing proteinuria after childbirth, and this was verified in the present study.
The PNR also increases with increasing proteinuria until childbirth in PE women. 7 This has been interpreted as indicating that as yet unknown factor(s) associated with PE caused a phenotypic alteration of glomerular podocytes, that is, reduced nephrin mRNA expression; and that glomerular podocytes with reduced nephrin mRNA expression are likely to detach from the GBM, resulting in increased podocyturia in which podocytes with reduced podocin mRNA are abundant. 7 Thus, abundant podocytes with reduced nephrin mRNA expression are characteristic of pathological podocyturia associated with PE. This process occurring during pregnancy is also ameliorated by childbirth: in the present study, PNR and proteinuria decreased gradually with increasing number of days after childbirth. This suggests that phenotype alteration of glomerular podocytes (i.e. decrease in nephrin mRNA expression in glomerular podocytes) gradually diminished with increasing number of days after childbirth in women following PE.
Podocyturia and PNR, however, were still significantly greater even after proteinuria decreased to a level similar to that in women following NCP in this study. The 19 post-partum urine samples with P/Cr 0.005-0.1 mg/mg were sampled approximately 1 month after birth (Fig. 3) . This suggests that pathological processes leading to decreased nephrin mRNA expression in the glomerular podocytes were still active even after normalization of proteinuria in women following PE pregnancy. Thus, pathological podocyturia persisted for approximately 1 month after birth in women following PE pregnancy in this study, consistent with the White et al. study in which frequency of podocyturia at 5-8 weeks after birth was significantly greater in PE women than in NCP women.
14 Hence, the assumed PE pregnancy decrease in the number of glomerular podocytes may also extend into the postpartum period after PE pregnancy. Given that podocytes are terminally differentiated cells, 1 and their turnover rate is very low, 8, 9 the detachment of podocytes from the GBM causes a long-lasting decrease in number of podocytes in the kidneys. 1, 10 Animal models suggested that podocyte depletion in the kidney is associated with end-stage kidney disease (ESKD) regardless of the cause of kidney disease. 13, 16 Indeed, decreased nephrin expression is seen in the kidneys of PE women, 17, 18 suggesting decreased number of podocytes in the kidney and or decreased nephrin expression in the glomerular podocytes of PE women. PE is a prominent risk factor for ESKD; 19 in women with three or more pregnancies, those with one PE pregnancy have a relative ESKD risk of 6.3 (95%CI: 4.1-9.9), while those with two PE pregnancies have a relative ESKD risk of 15.5 (95%CI: 7.8-30.8) compared with women with no PE pregnancies. 19 In an animal model, angiotensin receptor blocker (ARB) had a renoprotective effect via podocyte protection, 20 and was indeed shown to confer significant renal benefits in patients with type 2 diabetes and nephropathy, resulting in reduced proteinuria. 21 Although contraindicated in pregnancy, 22 use of ARB can be considered for renoprotection in post-partum women after PE pregnancy.
In conclusion, podocyturia decreased with decreasing proteinuria in women following PE. Also, pathological podocyturia (consisting of abundant podocytes with decreased nephrin mRNA expression) persisted, even after proteinuria decreased to a level similar to that in women following NCP, suggesting long-lasting podocyte injury in the kidney after PE pregnancy.
